Search clinical trials for: LXH254
Total 7 results
-
Novartis PharmaceuticalsTerminatedMelanoma | Ovarian Cancer | NSCLC | Other Solid TumorsItaly, Spain, Netherlands, France, Korea, Republic of, Switzerland, Germany, Japan, United States, Canada
-
Novartis PharmaceuticalsActive, not recruitingMelanomaUnited States, Italy, Belgium, Germany, Argentina, Australia, Israel, Netherlands, Switzerland, France, United Kingdom, Norway
-
Novartis PharmaceuticalsActive, not recruitingMelanoma | Non-Small Cell Lung CancerItaly, Australia, Belgium, Germany, Spain, Korea, Republic of, Israel, France, United States, Sweden, Poland
-
Erasca, Inc.RecruitingAdvanced or Metastatic Solid TumorsUnited States, Canada, Korea, Republic of, United Kingdom, Australia
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Erasca, Inc.Not yet recruitingAdvanced or Metastatic NRAS-mutant Melanoma
-
Novartis PharmaceuticalsActive, not recruitingBRAF V600 Colorectal CancerBelgium, Germany, Netherlands, Spain, Singapore, Australia, United Kingdom, Israel, Canada, United States